{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-23-067061","form_type":"8-K","ticker":"NMTC","cik":"0001500198","company_name":"NEUROONE MEDICAL TECHNOLOGIES Corp","filed_at":"2023-08-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:34.114811+00:00","generated_at":"2026-06-11T10:51:24.105943+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"NeuroOne Q3 FY2023 product revenue $630K, up from $32K; net loss $3.5M","bullets":["Product revenue $630K in Q3 FY2023 vs $32K YoY; collaboration revenue $1.46M in 9M.","Net loss $3.5M in Q3 vs $2.8M prior year; cash $3.1M at June 30 vs $8.1M at Sept 30.","Evo sEEG limited launch completed; full launch with Zimmer Biomet expected Q4. OneRF 510(k) submitted June 8.","Closed public offering net $5.2M and ATM net $2.5M in July 2023; no debt."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-23-067061","json":"https://secwatch.observer/filing/0001213900-23-067061.json","markdown":"https://secwatch.observer/filing/0001213900-23-067061.md","text":"https://secwatch.observer/filing/0001213900-23-067061.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1500198/000121390023067061/0001213900-23-067061-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1500198/000121390023067061/ea183383-8k_neuroone.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-11T10:51:24.105943+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"7f6c286ca8d445811529a30ed0eb778e3019552c","claim":"NEUROONE MEDICAL TECHNOLOGIES Corp reported fiscal third quarter 2023 ended June 30, 2023 results: revenue Product revenue was $630,000 in the fiscal third quarter 2023, net income Net loss was $3.5 million for the fiscal third quarter 2023.","evidence_excerpt":"On August 14, 2023, NeuroOne Medical Technologies Corporation (the “Company”) issued a press release announcing its financial results for the fiscal quarter ended June 30, 2023.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1500198/000121390023067061/0001213900-23-067061-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"fiscal third quarter 2023 ended June 30, 2023"},{"label":"Revenue","value":"Product revenue was $630,000 in the fiscal third quarter 2023"},{"label":"Net income","value":"Net loss was $3.5 million for the fiscal third quarter 2023"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}